A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall-Reference-Cited by-同舟云学术

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall

Published:2002-07 Issue:1 Volume:36 Page:158-163
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Nagashima Hirotaka,Aoka Yoshikazu,Sakomura Yasunari,Sakuta Akiko,Aomi Shigeyuki,Ishizuka Naoko,Hagiwara Nobuhisa,Kawana Masatoshi,Kasanuki Hiroshi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aortic Uptake of ¹⁸ F-NaF and ¹⁸ F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-09

2. Medical treatments for abdominal aortic aneurysm: an overview of clinical trials;Expert Opinion on Investigational Drugs;2024-07-11

3. An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome;Drug Discovery Today;2024-07

4. The effect of exercise training intervention for patients with abdominal aortic aneurysm on cardiovascular and cardiorespiratory variables: an updated meta-analysis of randomized controlled trials;BMC Cardiovascular Disorders;2024-01-30

5. The effects of statin therapy on aneurysm size, growth rate, and matrix metalloproteinases-9 levels in patients with aortic aneurysm: a systematic review and meta-analysis;The Egyptian Heart Journal;2023-10-13